Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Allergic Asthma”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT00079937
What this trial is testing

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 628
Not applicableLooking for participantsNCT07786870
What this trial is testing

Expression of TSLP Isoforms in Asthma

Who this might be right for
Asthma AtopicAsthma Severe Persistent Uncontrolled
Medical University of Warsaw 70
Post-approval studies (Phase 4)Study completedNCT01430403
What this trial is testing

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

Who this might be right for
Asthma
National Institute of Allergy and Infectious Diseases (NIAID) 478
Not applicableUnknownNCT02033252
What this trial is testing

Acupuncture for Rhinitis Complicated With Asthma

Who this might be right for
Allergic RhinitisAsthma
Jun-Yong Choi 30
Post-approval studies (Phase 4)Study completedNCT00870584
What this trial is testing

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 271
Testing effectiveness (Phase 2)Ended earlyNCT01591343
What this trial is testing

Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma

Who this might be right for
Allergic RhinitisRhinoconjunctivitisMild Persistent Asthma+1 more
Laboratorios Leti, S.L. 8
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Testing effectiveness (Phase 2)Study completedNCT03774290
What this trial is testing

Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients

Who this might be right for
Asthma
Palobiofarma SL 107
Post-approval studies (Phase 4)Study completedNCT00329381
What this trial is testing

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

Who this might be right for
Asthma
University of Mississippi Medical Center 14
Not applicableStudy completedNCT01147224
What this trial is testing

ATEM (Alvesco Non-interventional Study)

Who this might be right for
AsthmaAllergy
AstraZeneca 400
Testing effectiveness (Phase 2)WithdrawnNCT00598104
What this trial is testing

Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma

Who this might be right for
Asthma
Novartis
Post-approval studies (Phase 4)Study completedNCT00903227
What this trial is testing

Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis

Who this might be right for
AsthmaAllergic Rhinitis
University of Dundee 25
Large-scale testing (Phase 3)Study completedNCT00500539
What this trial is testing

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.

Who this might be right for
Asthma
Novartis 155
Testing effectiveness (Phase 2)Study completedNCT00890734
What this trial is testing

CYT003-QbG10 for Treatment of Allergic Asthma Bronchial

Who this might be right for
Allergic Bronchial Asthma
Cytos Biotechnology AG 63
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Post-approval studies (Phase 4)Study completedNCT00157937
What this trial is testing

Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

Who this might be right for
AsthmaAllergic Rhinitis
Organon and Co 31
Large-scale testing (Phase 3)Study completedNCT00046748
What this trial is testing

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 484
Post-approval studies (Phase 4)Study completedNCT00567476
What this trial is testing

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

Who this might be right for
Asthma
Novartis 116
Post-approval studies (Phase 4)Ended earlyNCT02953106
What this trial is testing

Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis

Who this might be right for
Asthma, AllergicRhinitis,AllergicAllergy
University of Dundee 7
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Next Page